ADC Therapeutics SA (NYSE:ADCT) shares could be 50% below their estimated intrinsic value
Key findings Using the 2-step free cash flow to equity, the estimated fair value of ADC Therapeutics is $6.30. ADC Therapeutics is estimated to be...